| Name | 4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid | 
|---|---|
| Synonyms | MLN9708 cc-436 UNII:E8R04MBQ04 4-(Carboxymethyl)-2-[(1R)-1-{[N-(2,5-dichlorobenzoyl)glycyl]amino}-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid S2181_Selleck 1,3,2-Dioxaborinane-4-acetic acid, 4-carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo- Ixazomib Citrate | 
| Density | 1.5±0.1 g/cm3 | 
|---|---|
| Molecular Formula | C20H23BCl2N2O9 | 
| Molecular Weight | 517.122 | 
| Exact Mass | 516.087341 | 
| PSA | 175.31000 | 
| LogP | 3.37810 | 
| Index of Refraction | 1.580 | 
| ~95%   1201902-80-8 | 
| Literature: MILLENNIUM PHARMACEUTICALS, INC. Patent: WO2009/154737 A1, 2009 ; Location in patent: Page/Page column 63 ; | 
| Precursor 2 | |
|---|---|
| DownStream 0 | |